Similar articles

• Antiplatelet therapy: a neurology perspective.

  Brass LM. Brass LM. Manag Care. 2000 Oct;9(10 Suppl):13-5. Manag Care. 2000. PMID: 11729420 No abstract available.
• Antiplatelet therapy: a neurology perspective.

  Brass LM. Brass LM. Manag Care. 2000 May;9(5 Suppl):15-7. Manag Care. 2000. PMID: 11729408 No abstract available.
• Combination antiplatelet agents for secondary prevention of ischemic stroke.

  Vande Griend JP, Saseen JJ. Vande Griend JP, et al. Pharmacotherapy. 2008 Oct;28(10):1233-42. doi: 10.1592/phco.28.10.1233. Pharmacotherapy. 2008. PMID: 18823219 Review.
• [Secondary stroke prevention according to the PRoFESS Study. What are the sequelae for practical therapy?].

  Diener C. Diener C. MMW Fortschr Med. 2008 May 22;150(21):7. MMW Fortschr Med. 2008. PMID: 18578065 German. No abstract available.
• [Platelet-function inhibitors in the secondary prevention of ischemic stroke].

  Busse O, Diener HC, Grond M. Busse O, et al. Dtsch Med Wochenschr. 2006 Nov;131 Suppl 5:S132-4. doi: 10.1055/s-2006-955052. Dtsch Med Wochenschr. 2006. PMID: 17089258 Review. German. No abstract available.